
SF Healthcare Week: Biohaven's Chairman & CEO Vlad Coric shares updates on the company's pipeline in immunology, obesity, and epilepsy
BiotechTV - News
00:00
Degrader platform and IGAN data preview
Vlad previews Biohaven's degrader immunology platform, its precision aims, and imminent initial IGAN patient data release.
Play episode from 04:48
Transcript


